SCHEMBL4698272

SCHEMBL4698272

O=C1CCN(C(=O)CCc2ccccc2)CC1

nearest known ligand 0.73

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.73
TDP1 Q9NUW8 1/20 0.73
FKBP1A P62942 1/20 0.67
POLB P06746 2/20 0.63
NAAA Q02083 1/20 0.60
L3MBTL1 Q9Y468 2/20 0.60
TSHR P16473 1/20 0.60
KMT2A Q03164 3/20 0.58
ME2 P23368 2/20 0.58
ME1 P48163 2/20 0.58
ME3 Q16798 2/20 0.58
PKM P14618 1/20 0.58
MAPT P10636 2/20 0.57
GFER P55789 1/20 0.57
MEN1 O00255 1/20 0.57
ALDH1A1 P00352 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.54
HPGD P15428 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7447522 0.89 NAAA (0.58) NPC1TDP1FKBP1ANAAAKMT2A
SCHEMBL7131839 0.88 NPC1 (0.86) NPC1TDP1FKBP1APOLBNAAA
SCHEMBL19584983 0.86 NPC1 (0.54) NPC1TDP1FKBP1APOLBNAAA
SCHEMBL25432319 0.84 NPC1 (0.93) NPC1TDP1FKBP1APOLBNAAA
SCHEMBL3700679 0.84 NPC1 (1.00) NPC1TDP1FKBP1APOLBNAAA
SCHEMBL17087869 0.83 NPC1 (0.96) NPC1TDP1FKBP1APOLBNAAA
SCHEMBL6285963 0.83 NPC1 (0.96) NPC1TDP1FKBP1APOLBNAAA
SCHEMBL643368 0.83 PKM (0.70) POLBL3MBTL1TSHRKMT2AME2
SCHEMBL8413137 0.83 NPC1 (0.67) NPC1TDP1FKBP1APOLBNAAA
SCHEMBL3796874 0.81 NPC1 (0.75) NPC1TDP1FKBP1APOLBNAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12466805-B2 Pharmaceutical compounds ALMAC DISCOVERY LIMITED (GB) 2025-11-11 US disclosed
CN-109790146-B Pharmaceutical compounds 阿尔麦克探索有限公司 2022-08-23 CN disclosed
EP-4026832-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 Almac Discovery Limited (GB) 2022-07-13 EP disclosed
EP-3490982-B1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LTD (GB) 2022-04-20 EP disclosed
US-20220002264-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2022-01-06 US disclosed
US-11053213-B2 Pharmaceutical compounds ALMAC DISCOVERY LIMITED (GB) 2021-07-06 US disclosed
US-10766903-B2 Piperidine derivatives as inhibitors of ubiquitin specific protease 7 ALMAC DISCOVERY LIMITED (GB) 2020-09-08 US disclosed
EP-3529241-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 Almac Discovery Limited (GB) 2019-08-28 EP disclosed
US-20190256518-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 GENETECH, INC. 2019-08-22 US disclosed
CN-110088096-A Piperidine derivatives as inhibitors of ubiquitin-specific protease 7 阿尔麦克探索有限公司 2019-08-02 CN disclosed
EP-1234824-A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation Dow AgroSciences LLC (US) 2002-08-28 EP disclosed
EP-1234823-A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation Dow AgroSciences LLC (US) 2002-08-28 EP disclosed
EP-1204643-A2 FUNGICIDAL HETEROCYCLIC AROMATIC AMIDES AND THEIR COMPOSITIONS, METHODS OF USE AND PREPARATION Dow AgroSciences LLC (US) 2002-05-15 EP disclosed
EP-1196388-A2 FUNGICIDAL HETEROCYCLIC AROMATIC AMIDES AND THEIR COMPOSITIONS, METHODS OF USE AND PREPARATION Dow AgroSciences LLC (US) 2002-04-17 EP disclosed
US-6355660-B1 HETEROCYCLIC FUNGICIDES SUBSTITUTED WITH AMIDE GROUPS DOW AGROSCIENCES LLC 2002-03-12 US disclosed
WO-2001014339-A2 FUNGICIDAL HETEROCYCLIC AROMATIC AMIDES AND THEIR COMPOSITIONS, METHODS OF USE AND PREPARATION DOW AGROSCIENCES LLC (US) 2001-03-01 WO disclosed
WO-2001005769-A2 FUNGICIDAL HETEROCYCLIC AROMATIC AMIDES AND THEIR COMPOSITIONS, METHODS OF USE AND PREPARATION DOW AGROSCIENCES LLC (US) 2001-01-25 WO disclosed
US-5466687-A Anticholesterol agents DR. KARL THOMAE GMBH (DE) 1995-11-14 US disclosed
EP-0596326-B1 Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing the same, use thereof and precesses for their production THOMAE GMBH DR K (DE) 1995-08-23 EP disclosed
EP-0596326-A1 Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing the same, use thereof and precesses for their production Dr. Karl Thomae GmbH (DE) 1994-05-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12466805-B2 Pharmaceutical compounds USP19, USP18, UBE2I NPC1 457/4885TDP1 1951/4885FKBP1A 900/4885
US-20190256518-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 USP7, USP5, UBA7 NPC1 2824/4885TDP1 1878/4885FKBP1A 1920/4885
US-20220002264-A1 PHARMACEUTICAL COMPOUNDS USP19, USP18, UBE2I NPC1 457/4885TDP1 1951/4885FKBP1A 900/4885
US-11053213-B2 Pharmaceutical compounds USP19, USP18, UBE2I NPC1 457/4885TDP1 1951/4885FKBP1A 900/4885
US-10766903-B2 Piperidine derivatives as inhibitors of ubiquitin specific protease 7 USP7, USP5, UBA7 NPC1 2824/4885TDP1 1878/4885FKBP1A 1920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.